MK-8457 100 mg

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Rheumatoid ArthritisRheumatoid Arthritis (RA)

Phase 2

Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)

TerminatedNCT01569152

Merck Sharp & Dohme LLCRheumatoid Arthritis (RA)

Start: 2012-05-22End: 2013-10-03Updated: 2019-03-27

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)

TerminatedNCT01651936

Merck Sharp & Dohme LLCRheumatoid Arthritis

Start: 2012-08-29End: 2013-10-08Updated: 2021-07-30